DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages.


OBJECTIVE Glipitins are widely used for the treatment of type 2 diabetic patients. In addition to their improvement of glycemic control, animal studies have suggested an independent anti-atherosclerotic effect of gliptins. Nevertheless, recent clinical trials regarding long-term effects of gliptin therapy on vascular events have been disappointing. This… (More)
DOI: 10.1016/j.ijcard.2015.07.044


6 Figures and Tables